Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors

Compared with adjacent unaffected skin, CirAE lesions had significantly upregulated <i>THY1</i> (<i>CD90</i>) and increased M2 macrophages (adjusted p<0.05). Our findings suggest that CirAEs exhibit diverse histologic patterns that may mimic autoimmune skin diseases. The lack of distinct biomarker signatures may indicate complex and heterogeneous mechanisms underlying CirAEs; however, the upregulation of <i>THY1</i> and elevated numbers of M2 macrophages in CirAE lesions suggest <i>THY1</i> and M2 macrophages may be involved in the pathogenesis of these toxic effects. Further investigation to elucidate the molecular determinants of CirAEs and develop targeted therapeutic strategies is warranted.

Authors

Institutions

Publication Details

Journal
Journal for ImmunoTherapy of Cancer
Published
2025-08-01
DOI
https://doi.org/10.1136/jitc-2024-011401
Citations
4
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
4.18

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors

Aung Naing, Nejla Ozirmak Lermi, Dzifa Y. Duose, Jonathan L. Curry et al.
4 citations
Journal for ImmunoTherapy of Cancer
Cancer Immunotherapy and Biomarkers
4.18
article

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors

Aung Naing, Nejla Ozirmak Lermi, Dzifa Y. Duose, Jonathan L. Curry, Cara Haymaker, Joud Hajjar, Omar Pacha, Anisha B. Patel, Ken Chen
article en
4 citations

Abstract

Compared with adjacent unaffected skin, CirAE lesions had significantly upregulated <i>THY1</i> (<i>CD90</i>) and increased M2 macrophages (adjusted p<0.05). Our findings suggest that CirAEs exhibit diverse histologic patterns that may mimic autoimmune skin diseases. The lack of distinct biomarker signatures may indicate complex and heterogeneous mechanisms underlying CirAEs; however, the upregulation of <i>THY1</i> and elevated numbers of M2 macrophages in CirAE lesions suggest <i>THY1</i> and M2 macrophages may be involved in the pathogenesis of these toxic effects. Further investigation to elucidate the molecular determinants of CirAEs and develop targeted therapeutic strategies is warranted.

Journal for ImmunoTherapy of CancerVol. 13(8)
The University of Texas MD Anderson Cancer Center (US), Texas Children's Hospital (US)
University of Texas MD Anderson Cancer Center
Good health and well-being
Openalex Percentile: Top 5%
Cancer Immunotherapy and Biomarkers
4.18
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Histologic and immune characterization of cutaneous immune-related adverse events induced by immune checkpoint inhibitors — Aung Naing, Nejla Ozirmak Lermi, et al. · Journal for ImmunoTherapy of Cancer (2025) | TGRS Research Map | TGRS